Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tobira appoints CEO and CFO from Jennerex

This article was originally published in Scrip

Executive Summary

Clinical-stage biopharma company Tobira Therapeutics has named its chair, Dr Laurent Fischer, CEO, and has appointed Christopher Peetz CFO. The appointments follow the resignations of former CEO and CFO Andrew Hindman and Carolyn Loewy respectively. Dr Fischer most recently served as chair and CEO of Jennerex, while Mr Peetz also served at Jennerex as vice-president, finance & corporate development.

Advertisement

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC024942

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel